132 related articles for article (PubMed ID: 34129471)
1. The recurrent urinary tract infection health and functional impact questionnaire (RUHFI-Q): design and feasibility assessment of a new evaluation scale.
Croghan SM; Khan JSA; Jacob PT; Flood HD; Giri SK
Can J Urol; 2021 Jun; 28(3):10729-10732. PubMed ID: 34129471
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the quality of life impact of recurrent urinary tract infection: Validation and refinement of the Recurrent UTI Impact Questionnaire (RUTIIQ).
Newlands AF; Kramer M; Roberts L; Maxwell K; Price JL; Finlay KA
Neurourol Urodyn; 2024 Apr; 43(4):902-914. PubMed ID: 38385648
[TBL] [Abstract][Full Text] [Related]
3. Development and psychometric validation of a patient-reported outcome measure of recurrent urinary tract infection impact: the Recurrent UTI Impact Questionnaire.
Newlands AF; Roberts L; Maxwell K; Kramer M; Price JL; Finlay KA
Qual Life Res; 2023 Jun; 32(6):1745-1758. PubMed ID: 36740638
[TBL] [Abstract][Full Text] [Related]
4. Standardised Chinese herbal treatment delivered by GPs compared with individualised treatment administered by practitioners of Chinese herbal medicine for women with recurrent urinary tract infections (RUTI): study protocol for a randomised controlled trial.
Flower A; Harman K; Lewith G; Moore M; Bishop FL; Stuart B; Lampert N
Trials; 2016 Jul; 17():358. PubMed ID: 27460108
[TBL] [Abstract][Full Text] [Related]
5. Recurrent urinary tract infection management and prevention techniques among a population-based cohort of women.
Gleicher S; Sebesta EM; Kaufman MR; Dmochowski RR; Reynolds WS
Neurourol Urodyn; 2023 Nov; 42(8):1676-1685. PubMed ID: 37670465
[TBL] [Abstract][Full Text] [Related]
6. Potential host-related risk factors for recurrent urinary tract infection in Saudi women of childbearing age.
Ahmed AF; Solyman AA; Kamal SM
Int Urogynecol J; 2016 Aug; 27(8):1245-53. PubMed ID: 26872648
[TBL] [Abstract][Full Text] [Related]
7. The Recurrent Urinary Tract Infection Symptom Scale: Development and validation of a patient-reported outcome measure.
Newlands AF; Roberts L; Maxwell K; Kramer M; Price JL; Finlay KA
BJUI Compass; 2023 May; 4(3):285-297. PubMed ID: 37025478
[TBL] [Abstract][Full Text] [Related]
8. Factors Associated With a Positive Urine Culture in Women Seeking Urogynecologic Care for Urinary Tract Infection Symptoms.
Meckes NA; Melnyk AI; Guirguis M; Zyczynski H; Bradley MS
Female Pelvic Med Reconstr Surg; 2022 Jul; 28(7):408-413. PubMed ID: 35421014
[TBL] [Abstract][Full Text] [Related]
9. Assessment and treatment of recurrent urinary tract infections in women: development of a questionnaire based on a qualitative study of patient expectations in secondary care.
Pat JJ; Aart TVD; Steffens MG; Witte LPW; Blanker MH
BMC Urol; 2020 Dec; 20(1):190. PubMed ID: 33267816
[TBL] [Abstract][Full Text] [Related]
10. Definition of Recurrent Urinary Tract Infections in Women: Which One to Adopt?
Malik RD; Wu YR; Zimmern PE
Female Pelvic Med Reconstr Surg; 2018; 24(6):424-429. PubMed ID: 29135809
[TBL] [Abstract][Full Text] [Related]
11. Prevention of recurrent urinary tract infections.
Wagenlehner FM; Vahlensieck W; Bauer HW; Weidner W; Piechota HJ; Naber KG
Minerva Urol Nefrol; 2013 Mar; 65(1):9-20. PubMed ID: 23538307
[TBL] [Abstract][Full Text] [Related]
12. Development and feasibility of a telemedicine tool for patients with recurrent urinary tract infection: myRUTIcoach.
Pat JJ; Pape CCET; Steffens MG; Witte LPW; Blanker MH
Int Urogynecol J; 2023 Nov; 34(11):2817-2825. PubMed ID: 37755525
[TBL] [Abstract][Full Text] [Related]
13. Role of the bacterial vaccine Solco-Urovac® in treatment and prevention of recurrent urinary tract infections of bacterial origin.
Kochiashvili D; Khuskivadze A; Kochiashvili G; Koberidze G; Kvakhajelidze V
Georgian Med News; 2014 Jun; (231):11-6. PubMed ID: 25020163
[TBL] [Abstract][Full Text] [Related]
14. Urinary NGAL deficiency in recurrent urinary tract infections.
Forster CS; Johnson K; Patel V; Wax R; Rodig N; Barasch J; Bachur R; Lee RS
Pediatr Nephrol; 2017 Jun; 32(6):1077-1080. PubMed ID: 28210838
[TBL] [Abstract][Full Text] [Related]
15. Sporadic compared to recurrent urinary tract infections: Considerations for urogynecologic patients.
Bradley MS; Cabrera C; Clark SG; Sassani J; Venuti K; Ackenbom MF
Neurourol Urodyn; 2020 Nov; 39(8):2186-2191. PubMed ID: 32803912
[TBL] [Abstract][Full Text] [Related]
16. Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women.
Czaja CA; Stamm WE; Stapleton AE; Roberts PL; Hawn TR; Scholes D; Samadpour M; Hultgren SJ; Hooton TM
J Infect Dis; 2009 Aug; 200(4):528-36. PubMed ID: 19586416
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
18. Reducing Recurrent Urinary Tract Infections in Women with MV140 Impacts Personal Burden of Disease: Secondary Analyses of a Randomized Placebo-controlled Efficacy Study.
Curtis Nickel J; Foley S; Yang B; Casanovas M; Caballero R; Diez-Rivero CM; Lorenzo-Gómez MF
Eur Urol Open Sci; 2024 May; 63():96-103. PubMed ID: 38585593
[TBL] [Abstract][Full Text] [Related]
19. Exploring the relationship between self-reported urinary tract infections to quality of life and associated conditions: insights from the spinal cord injury Community Survey.
Locke JA; Welk B; Macnab A; Rivers CS; Kurban D; Nigro M; Stothers L
Spinal Cord; 2019 Dec; 57(12):1040-1047. PubMed ID: 31289367
[TBL] [Abstract][Full Text] [Related]
20. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
Ejrnæs K
Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
